Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Short Interest Update

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) was the recipient of a significant drop in short interest in October. As of October 31st, there was short interest totalling 7,100 shares, a drop of 84.2% from the October 15th total of 44,900 shares. Based on an average daily volume of 14,100 shares, the days-to-cover ratio is presently 0.5 days.

Awakn Life Sciences Price Performance

Shares of OTCMKTS:AWKNF remained flat at $0.09 on Thursday. 13,950 shares of the company’s stock were exchanged, compared to its average volume of 14,729. The business has a 50-day moving average price of $0.08 and a 200-day moving average price of $0.09. Awakn Life Sciences has a 1-year low of $0.04 and a 1-year high of $0.19.

Awakn Life Sciences Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.